85 related articles for article (PubMed ID: 12755022)
1. [Development of a novel targeted therapy for human glioblastoma].
Ishiuchi S
No Shinkei Geka; 2003 May; 31(5):495-500. PubMed ID: 12755022
[No Abstract] [Full Text] [Related]
2. Excitatory amino acid receptors and antiepileptic drug development.
Meldrum BS; Chapman AG
Adv Neurol; 1999; 79():965-78. PubMed ID: 10514879
[No Abstract] [Full Text] [Related]
3. Depressor responses to L-proline microinjected into the rat ventrolateral medulla are mediated by ionotropic excitatory amino acid receptors.
Takemoto Y
Auton Neurosci; 2005 Jun; 120(1-2):108-12. PubMed ID: 15964784
[TBL] [Abstract][Full Text] [Related]
4. Glutamate as a therapeutic target in psychiatric disorders.
Javitt DC
Mol Psychiatry; 2004 Nov; 9(11):984-97, 979. PubMed ID: 15278097
[TBL] [Abstract][Full Text] [Related]
5. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
Howells FM; Russell VA
Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
[TBL] [Abstract][Full Text] [Related]
6. Response properties of antral mechanosensitive afferent fibers and effects of ionotropic glutamate receptor antagonists.
Sengupta JN; Petersen J; Peles S; Shaker R
Neuroscience; 2004; 125(3):711-23. PubMed ID: 15099685
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection.
Radenovic L; Selakovic V
Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172
[TBL] [Abstract][Full Text] [Related]
8. Glutamate receptor subtypes: promising new pharmacotherapeutic targets.
Higgins GA; Miczek KA
Psychopharmacology (Berl); 2005 Apr; 179(1):1-3. PubMed ID: 15761696
[No Abstract] [Full Text] [Related]
9. Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate.
Lin TH; Yang RS; Tang CH; Wu MY; Fu WM
Eur J Pharmacol; 2008 Jul; 589(1-3):37-44. PubMed ID: 18538763
[TBL] [Abstract][Full Text] [Related]
10. Searching for rational anti N-methyl-D-aspartate treatment for depression.
Tsai GE
Arch Gen Psychiatry; 2007 Sep; 64(9):1099-100; author reply 1100-1. PubMed ID: 17768278
[No Abstract] [Full Text] [Related]
11. Stimulation of NMDA and AMPA glutamate receptors elicits distinct concentration dynamics of nitric oxide in rat hippocampal slices.
Frade JG; Barbosa RM; Laranjinha J
Hippocampus; 2009 Jul; 19(7):603-11. PubMed ID: 19115375
[TBL] [Abstract][Full Text] [Related]
12. Glutamate and the glutamate receptor system: a target for drug action.
Bleich S; Römer K; Wiltfang J; Kornhuber J
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S33-40. PubMed ID: 12973748
[TBL] [Abstract][Full Text] [Related]
13. Development of glutamate receptors in auditory neurons from long-term organotypic cultures of the embryonic chick hindbrain.
Diaz C; Martinez-Galan JR; Juiz JM
Eur J Neurosci; 2009 Jan; 29(2):213-30. PubMed ID: 19200228
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of argiotoxin 636 and analogues: selective antagonists for ionotropic glutamate receptors.
Nelson JK; Frølund SU; Tikhonov DB; Kristensen AS; Strømgaard K
Angew Chem Int Ed Engl; 2009; 48(17):3087-91. PubMed ID: 19152392
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of N-methyl-D-aspartate receptors, AMPA receptors or metabotropic glutamate receptors leads to rapid internalization of AMPA receptors in cultured nucleus accumbens neurons.
Mangiavacchi S; Wolf ME
Eur J Neurosci; 2004 Aug; 20(3):649-57. PubMed ID: 15255976
[TBL] [Abstract][Full Text] [Related]
16. Antagonists of glutamate in the treatment of Parkinson's disease: from laboratory to the clinic.
Starr MS
Amino Acids; 1998; 14(1-3):41-2. PubMed ID: 9871439
[No Abstract] [Full Text] [Related]
17. Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.
Ishiuchi S; Tsuzuki K; Yoshida Y; Yamada N; Hagimura N; Okado H; Miwa A; Kurihara H; Nakazato Y; Tamura M; Sasaki T; Ozawa S
Nat Med; 2002 Sep; 8(9):971-8. PubMed ID: 12172541
[TBL] [Abstract][Full Text] [Related]
18. 3-hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists.
Colotta V; Catarzi D; Varano F; Calabri FR; Filacchioni G; Costagli C; Galli A
Bioorg Med Chem Lett; 2004 May; 14(9):2345-9. PubMed ID: 15081038
[TBL] [Abstract][Full Text] [Related]
19. The entry of manganese ions into the brain is accelerated by the activation of N-methyl-D-aspartate receptors.
Itoh K; Sakata M; Watanabe M; Aikawa Y; Fujii H
Neuroscience; 2008 Jun; 154(2):732-40. PubMed ID: 18495352
[TBL] [Abstract][Full Text] [Related]
20. Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat.
Yokoyama O; Mizuno H; Komatsu K; Akino H; Tanase K; Namiki M
J Urol; 2004 Apr; 171(4):1709-14. PubMed ID: 15017271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
